PEP-Therapy's Seed VC - II Round

PEP-Therapy raised a round of funding on November 27, 2017.

PEP-Therapy is a biotech company developing targeted therapies for the treatment of severe diseases, with an initial focus on cancer. PEP-Therapy develops Cell Penetrating and Interfering Peptides (CP…

Articles about PEP-Therapy's Seed VC - II Round: